URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Gary Morrow

Concepts (475)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
63
1982
155
13.110
Why?
Neoplasms
80
1978
743
11.900
Why?
Antineoplastic Agents
58
1982
628
8.440
Why?
Vomiting
39
1982
116
7.810
Why?
Fatigue
23
1996
124
7.370
Why?
Breast Neoplasms
27
1980
666
4.500
Why?
Antiemetics
20
1989
55
3.510
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1985
436
2.450
Why?
Vomiting, Anticipatory
10
1988
21
2.270
Why?
Middle Aged
84
1978
10013
2.040
Why?
Radiotherapy
9
1982
198
2.030
Why?
Quality of Life
21
1983
528
2.020
Why?
Humans
152
1966
37165
2.010
Why?
Behavior Therapy
12
1982
110
1.670
Why?
Female
96
1968
20222
1.650
Why?
Aged
60
1978
7392
1.630
Why?
Exercise
5
2006
181
1.620
Why?
Patient Education as Topic
8
1983
227
1.480
Why?
Bone Density Conservation Agents
2
2009
49
1.440
Why?
Adult
67
1978
11572
1.380
Why?
Prostatic Neoplasms
4
2002
540
1.370
Why?
Cognition Disorders
2
2011
291
1.230
Why?
Aged, 80 and over
23
1996
2588
1.200
Why?
Depression
10
1983
442
1.170
Why?
Male
69
1968
20139
1.170
Why?
European Continental Ancestry Group
2
2007
238
1.160
Why?
African Americans
2
2007
230
1.120
Why?
Survivors
4
2009
118
1.060
Why?
Benzhydryl Compounds
3
2005
13
1.030
Why?
Complementary Therapies
3
2005
39
1.020
Why?
Social Support
5
1984
233
1.020
Why?
Tai Ji
3
2010
22
0.990
Why?
Acupressure
3
2003
15
0.940
Why?
Osteoporosis
3
2009
83
0.890
Why?
Health Behavior
3
1994
115
0.880
Why?
Treatment Outcome
17
1993
2671
0.860
Why?
Cisplatin
6
1992
93
0.840
Why?
Boronic Acids
1
2012
30
0.840
Why?
Pyrazines
1
2012
34
0.830
Why?
Antibodies, Monoclonal, Humanized
1
2012
94
0.830
Why?
Clinical Trials as Topic
8
1980
685
0.830
Why?
Ginger
1
2011
5
0.820
Why?
Perception
5
1984
66
0.820
Why?
Double-Blind Method
10
1998
996
0.820
Why?
Stress Disorders, Post-Traumatic
2
2005
72
0.820
Why?
Multiple Myeloma
1
2012
75
0.810
Why?
Phytotherapy
1
2011
18
0.810
Why?
Smoking
3
2009
423
0.790
Why?
Medically Underserved Area
2
2008
31
0.790
Why?
Serotonin Antagonists
5
1995
21
0.790
Why?
Colorectal Neoplasms
2
2009
143
0.780
Why?
Ovarian Neoplasms
5
1992
106
0.750
Why?
Resistance Training
1
2010
7
0.750
Why?
Patient Satisfaction
5
2004
243
0.750
Why?
Vitamin D
1
2011
71
0.730
Why?
Autonomic Nervous System
4
1992
70
0.730
Why?
Exercise Tolerance
1
2009
12
0.720
Why?
Osteoporotic Fractures
1
2009
14
0.720
Why?
Questionnaires
14
1982
1061
0.710
Why?
Health Status Disparities
1
2010
47
0.700
Why?
Stress, Psychological
3
1983
290
0.700
Why?
Sleep Initiation and Maintenance Disorders
2
1985
45
0.690
Why?
Adaptation, Psychological
9
1978
212
0.690
Why?
Calcitriol
1
2009
80
0.690
Why?
Family
2
2007
208
0.680
Why?
Sleep Disorders
3
2002
70
0.670
Why?
Gene Expression Regulation, Neoplastic
1
2011
266
0.670
Why?
Anxiety
3
1978
107
0.650
Why?
Radiation Injuries
2
2005
131
0.640
Why?
Ondansetron
4
1995
11
0.640
Why?
Hot Flashes
3
2000
25
0.620
Why?
Cognition
2
1986
232
0.610
Why?
Paroxetine
2
2003
10
0.610
Why?
Fatigue Syndrome, Chronic
1
2007
11
0.600
Why?
Community Health Services
2
2006
80
0.590
Why?
Needs Assessment
1
2008
100
0.580
Why?
Attitude
3
1982
67
0.580
Why?
Bone and Bones
1
2010
360
0.580
Why?
Hydrocortisone
2
1989
133
0.580
Why?
Psychophysiology
1
2006
15
0.560
Why?
Antineoplastic Agents, Hormonal
2
2000
44
0.560
Why?
Emotions
1
2006
91
0.550
Why?
Skin Diseases
1
2007
121
0.550
Why?
Therapeutic Touch
1
2005
3
0.530
Why?
Conditioning, Classical
3
1991
36
0.530
Why?
Hypothalamo-Hypophyseal System
2
2001
55
0.520
Why?
Motion Sickness
6
1984
8
0.500
Why?
Patient Compliance
5
1982
177
0.490
Why?
Prevalence
6
1992
582
0.490
Why?
Social Adjustment
6
1978
81
0.480
Why?
Tamoxifen
2
2000
84
0.470
Why?
Serotonin Uptake Inhibitors
1
2003
35
0.470
Why?
Vagus Nerve
2
2000
39
0.470
Why?
Granisetron
3
1995
7
0.450
Why?
Research Design
5
1991
340
0.440
Why?
Primary Health Care
1
2008
518
0.440
Why?
Cytokines
4
2001
575
0.440
Why?
Platinum Compounds
1
2002
7
0.440
Why?
Doxorubicin
6
2003
105
0.440
Why?
Family Relations
1
2003
48
0.430
Why?
Patients
2
1984
48
0.430
Why?
Sex Factors
5
1983
613
0.420
Why?
United States
11
1979
2847
0.420
Why?
Risk Factors
9
1991
2331
0.410
Why?
Pilot Projects
4
2004
446
0.400
Why?
Acupuncture Therapy
3
2002
12
0.390
Why?
Physician-Patient Relations
9
1979
379
0.380
Why?
Clonidine
1
2000
34
0.370
Why?
Time Factors
7
1982
3234
0.370
Why?
Age Factors
7
1984
1152
0.370
Why?
Adrenergic alpha-Agonists
1
2000
37
0.370
Why?
Postmenopause
1
2000
42
0.370
Why?
Carboplatin
4
1995
29
0.360
Why?
Receptors, Serotonin
2
1998
12
0.360
Why?
Serotonin
3
2001
102
0.350
Why?
Bone Density
2
2009
114
0.350
Why?
Models, Psychological
4
1980
92
0.340
Why?
Pain
3
2006
392
0.330
Why?
Medicare
2
2009
147
0.330
Why?
Hypnosis
3
1988
16
0.330
Why?
Parasympathetic Nervous System
4
1992
15
0.330
Why?
Tobacco Smoke Pollution
2
2008
77
0.330
Why?
Attitude to Health
6
1978
228
0.320
Why?
Desensitization, Psychologic
3
1982
4
0.320
Why?
Severity of Illness Index
6
2000
943
0.310
Why?
Randomized Controlled Trials as Topic
2
1992
415
0.310
Why?
Statistics as Topic
3
1980
189
0.300
Why?
New York
5
2006
1378
0.300
Why?
Radiodermatitis
2
2006
8
0.300
Why?
Biological Markers
2
2009
564
0.290
Why?
Neoplasm Staging
5
1999
354
0.290
Why?
Analysis of Variance
3
2003
749
0.290
Why?
Psychometrics
4
1984
232
0.290
Why?
Placebo Effect
2
2006
36
0.290
Why?
Retrospective Studies
5
1986
2302
0.280
Why?
Psychotherapy, Group
3
1999
23
0.280
Why?
Health Knowledge, Attitudes, Practice
1
2000
296
0.280
Why?
Communication
3
2006
282
0.280
Why?
Palliative Care
1
1998
161
0.280
Why?
Odds Ratio
4
2008
323
0.280
Why?
Health Status Indicators
2
2002
112
0.280
Why?
Prognosis
6
1979
1078
0.270
Why?
Follow-Up Studies
8
1992
1889
0.270
Why?
Geriatric Assessment
3
2009
168
0.260
Why?
Adolescent
14
1981
5044
0.260
Why?
Behavioral Sciences
1
1994
5
0.250
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.250
Why?
Cyclohexanecarboxylic Acids
2
2004
46
0.240
Why?
Clinical Protocols
1
1994
107
0.240
Why?
Amines
2
2004
63
0.240
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.240
Why?
Dose-Response Relationship, Drug
2
2001
1142
0.240
Why?
Prochlorperazine
3
2005
11
0.240
Why?
gamma-Aminobutyric Acid
2
2004
97
0.240
Why?
Skin
2
2006
384
0.230
Why?
Logistic Models
3
2009
626
0.220
Why?
Drug Therapy, Combination
3
1979
397
0.220
Why?
Meta-Analysis as Topic
1
1992
36
0.220
Why?
Social Environment
2
1981
90
0.220
Why?
Blood Pressure
5
1978
468
0.220
Why?
Drug Administration Schedule
2
2009
374
0.220
Why?
Regression Analysis
4
1995
539
0.220
Why?
Parents
3
1978
182
0.210
Why?
Behavioral Medicine
2
1982
11
0.210
Why?
Oncologic Nursing
1
1992
9
0.210
Why?
Longitudinal Studies
3
1991
413
0.210
Why?
Psychology, Clinical
1
1992
5
0.210
Why?
Relaxation Therapy
3
1982
15
0.210
Why?
Informed Consent
3
1980
86
0.210
Why?
Sick Role
4
1991
48
0.210
Why?
Comorbidity
3
2006
377
0.210
Why?
Circadian Rhythm
3
1989
85
0.210
Why?
Drug Therapy
1
1992
48
0.200
Why?
Medical Oncology
1
1992
49
0.200
Why?
Massage
1
2011
9
0.200
Why?
Feasibility Studies
2
1999
212
0.200
Why?
Cyclophosphamide
4
1985
177
0.200
Why?
Risk
3
1982
355
0.190
Why?
Interleukin-6
2
2006
339
0.190
Why?
Vitamin D Deficiency
1
2011
36
0.190
Why?
Interleukin-8
1
2011
111
0.190
Why?
Energy Metabolism
1
2011
137
0.190
Why?
Dentate Gyrus
1
2010
26
0.190
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Chemokine CCL2
1
2011
128
0.180
Why?
Collagen Type I
1
2010
51
0.180
Why?
Intervention Studies
1
2009
35
0.180
Why?
Sexual Dysfunctions, Psychological
1
2009
2
0.180
Why?
Muscle Strength
1
2009
25
0.180
Why?
Peptides
3
1966
293
0.180
Why?
Tumor Markers, Biological
1
2011
240
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Food Preferences
1
1989
13
0.170
Why?
Body Image
1
2009
30
0.170
Why?
Wrist
3
2002
49
0.170
Why?
Blood-Brain Barrier
1
2010
110
0.170
Why?
Home Care Services
1
2009
48
0.170
Why?
Bulimia
1
1989
18
0.170
Why?
Conditioning (Psychology)
2
1984
29
0.170
Why?
Adrenocorticotropic Hormone
1
1989
76
0.170
Why?
Fetal Death
1
2008
54
0.170
Why?
Frail Elderly
1
2009
60
0.170
Why?
Placebos
3
2000
185
0.170
Why?
Continental Population Groups
1
2009
125
0.160
Why?
Psychotherapy, Brief
1
2008
8
0.160
Why?
Memory
1
2009
104
0.160
Why?
Brain Neoplasms
2
1985
282
0.160
Why?
Child
6
1978
4342
0.160
Why?
Infertility, Female
1
2008
57
0.160
Why?
Awareness
1
2008
34
0.160
Why?
Self Concept
1
2009
107
0.160
Why?
Bone Resorption
1
2010
245
0.160
Why?
Interleukin-1
2
2006
221
0.160
Why?
Activities of Daily Living
2
2001
273
0.160
Why?
Sickness Impact Profile
1
2007
40
0.150
Why?
Insulin
1
2011
670
0.150
Why?
Patient Care
1
2008
41
0.150
Why?
Outcome and Process Assessment (Health Care)
1
2008
90
0.150
Why?
Attention
1
2009
151
0.150
Why?
Health Promotion
2
1980
170
0.150
Why?
Survival Rate
1
2009
619
0.150
Why?
Drug Eruptions
1
2007
29
0.150
Why?
Young Adult
2
2008
1084
0.150
Why?
Case-Control Studies
1
2009
624
0.150
Why?
Life Style
1
2008
91
0.150
Why?
Life Change Events
1
2008
107
0.150
Why?
Cognitive Therapy
1
2007
41
0.140
Why?
Arousal
1
2006
56
0.140
Why?
Pituitary-Adrenal System
2
1989
36
0.140
Why?
Curcumin
1
2006
24
0.140
Why?
National Institutes of Health (U.S.)
1
2006
64
0.140
Why?
Radiation-Protective Agents
1
2006
41
0.140
Why?
Community Health Centers
2
2000
30
0.140
Why?
Academic Medical Centers
2
2003
94
0.140
Why?
Radiation Injuries, Experimental
1
2006
89
0.140
Why?
Muscles
1
2007
347
0.130
Why?
Psychological Tests
4
1978
83
0.130
Why?
Choice Behavior
1
2006
51
0.130
Why?
Program Evaluation
1
2006
225
0.130
Why?
Immune Tolerance
1
1986
150
0.130
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
7
0.130
Why?
Menopause
1
2005
38
0.130
Why?
Multivariate Analysis
4
1992
548
0.130
Why?
Antidepressive Agents, Second-Generation
1
2005
13
0.130
Why?
Professional-Patient Relations
2
2000
45
0.130
Why?
Data Interpretation, Statistical
2
1992
157
0.130
Why?
Valsalva Maneuver
3
1995
12
0.130
Why?
Self Efficacy
1
2005
49
0.130
Why?
Affective Symptoms
1
2005
53
0.130
Why?
Decision Making
2
1984
227
0.130
Why?
Aging
1
2011
705
0.130
Why?
Antidepressive Agents
2
1979
93
0.130
Why?
Demography
3
1992
103
0.120
Why?
Behavior
1
2004
54
0.120
Why?
Chronic Disease
1
2007
554
0.120
Why?
Lung Diseases
1
1986
224
0.120
Why?
Sympathetic Nervous System
2
1992
116
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.120
Why?
Self-Assessment
3
1984
51
0.120
Why?
Psychotherapy
1
2005
88
0.120
Why?
Acetates
1
2004
65
0.120
Why?
Patient Dropouts
2
1981
29
0.120
Why?
Physical Stimulation
1
2003
56
0.120
Why?
Educational Status
2
1980
182
0.120
Why?
Administration, Oral
2
2000
314
0.120
Why?
Glucocorticoids
1
2005
168
0.110
Why?
Conflict (Psychology)
1
2003
21
0.110
Why?
Health Status
3
2009
306
0.110
Why?
Stress Disorders, Traumatic
1
2002
4
0.110
Why?
Risk Assessment
2
1984
875
0.110
Why?
Occult Blood
1
1982
9
0.110
Why?
Cross-Sectional Studies
4
2002
676
0.110
Why?
Electroacupuncture
1
2002
2
0.110
Why?
Chi-Square Distribution
1
2003
347
0.110
Why?
Psychiatric Status Rating Scales
1
2003
332
0.110
Why?
Self Care
1
1982
60
0.100
Why?
Anemia
1
2001
78
0.100
Why?
Stomach
1
2001
80
0.100
Why?
Records as Topic
1
1980
7
0.100
Why?
Outcome Assessment (Health Care)
1
2003
301
0.100
Why?
Heart Rate
3
1978
457
0.090
Why?
Palpation
1
1980
13
0.090
Why?
Quality-Adjusted Life Years
1
2000
53
0.090
Why?
Sampling Studies
1
2000
50
0.090
Why?
Metoclopramide
1
1999
8
0.090
Why?
Syndrome
2
2009
209
0.090
Why?
Breast
1
1980
66
0.090
Why?
Cold Temperature
1
1999
97
0.090
Why?
Reproducibility of Results
3
1992
903
0.090
Why?
Body Temperature
2
1984
67
0.090
Why?
Posture
1
1999
112
0.090
Why?
Adenosine Triphosphate
1
2001
415
0.080
Why?
Data Collection
1
2000
231
0.080
Why?
Emetics
1
1998
4
0.080
Why?
Dexamethasone
2
2005
188
0.080
Why?
Catecholamines
1
1978
78
0.080
Why?
Fluorouracil
2
1985
78
0.080
Why?
Evidence-Based Medicine
1
1999
210
0.080
Why?
Hydroxyproline
2
1966
23
0.080
Why?
Carcinoma
1
1999
194
0.080
Why?
Weight Loss
2
2004
79
0.080
Why?
Animals
6
1967
16416
0.070
Why?
Pallor
2
1992
6
0.070
Why?
Pulse
2
1992
28
0.070
Why?
Hodgkin Disease
1
1978
156
0.070
Why?
Cardiovascular System
1
1996
47
0.070
Why?
Sensitivity and Specificity
1
2000
914
0.070
Why?
Signal Transduction
1
2006
1629
0.070
Why?
Prospective Studies
3
1982
1696
0.070
Why?
Counseling
2
1982
93
0.060
Why?
Indoles
1
1995
104
0.060
Why?
Ambulatory Care
1
1996
167
0.060
Why?
Disease Susceptibility
2
1984
80
0.060
Why?
Health Surveys
2
2004
234
0.060
Why?
Affect
2
1986
78
0.060
Why?
Infant, Newborn
3
1966
1836
0.060
Why?
Personality Inventory
2
1999
155
0.060
Why?
Vestibule, Labyrinth
2
1984
82
0.060
Why?
Research
1
1994
185
0.060
Why?
Anxiety Disorders
2
1985
56
0.060
Why?
Psychotropic Drugs
2
1979
38
0.060
Why?
Mental Disorders
3
1979
351
0.060
Why?
Receptors, Neurokinin-1
1
2012
7
0.060
Why?
Quinuclidines
1
2012
6
0.060
Why?
Blood Volume
1
1992
52
0.060
Why?
Intention to Treat Analysis
1
2012
10
0.060
Why?
Patient Selection
1
1994
223
0.060
Why?
Morpholines
1
2012
43
0.050
Why?
Mice, Inbred C57BL
2
2006
1700
0.050
Why?
Isoquinolines
1
2012
63
0.050
Why?
Lung Neoplasms
1
1996
435
0.050
Why?
Alprazolam
1
1991
1
0.050
Why?
Mice
3
2006
6206
0.050
Why?
Muscle Relaxation
1
1991
23
0.050
Why?
Nutrition Disorders
1
2011
15
0.050
Why?
Pregnancy
2
2004
1941
0.050
Why?
Individuality
1
1991
10
0.050
Why?
Hearing Disorders
1
2011
24
0.050
Why?
Body Temperature Regulation
1
1991
29
0.050
Why?
Urinary Incontinence
1
2011
44
0.050
Why?
Accidental Falls
1
2011
47
0.050
Why?
Infusions, Intravenous
1
1991
143
0.050
Why?
Benzodiazepines
1
2010
26
0.050
Why?
Memory Disorders
1
2011
48
0.050
Why?
Bromodeoxyuridine
1
2010
68
0.050
Why?
Vision Disorders
1
2011
73
0.050
Why?
Neurogenesis
1
2010
30
0.050
Why?
Paclitaxel
1
2010
59
0.050
Why?
Physicians
2
1979
161
0.050
Why?
Confounding Factors (Epidemiology)
1
2009
60
0.040
Why?
Mastectomy
1
2009
42
0.040
Why?
Disabled Persons
1
2009
63
0.040
Why?
Corticotropin-Releasing Hormone
1
1989
45
0.040
Why?
Vitamin B 12 Deficiency
1
1968
6
0.040
Why?
Residence Characteristics
1
2009
70
0.040
Why?
Metabolism, Inborn Errors
1
1968
9
0.040
Why?
Eating
1
1989
86
0.040
Why?
Malonates
1
1968
7
0.040
Why?
Hypothalamus
1
1989
89
0.040
Why?
Socioeconomic Factors
2
1981
425
0.040
Why?
Women's Health
1
2009
59
0.040
Why?
Community Mental Health Centers
1
2008
13
0.040
Why?
National Cancer Institute (U.S.)
1
2007
12
0.040
Why?
Body Weight
1
1989
337
0.040
Why?
Urban Health
1
2008
60
0.040
Why?
Maternal Exposure
1
2008
98
0.040
Why?
Child, Preschool
2
1981
2737
0.040
Why?
Learning
1
1989
144
0.040
Why?
Guideline Adherence
1
2008
87
0.040
Why?
Quality Indicators, Health Care
1
2007
62
0.040
Why?
Health Education
1
2008
91
0.040
Why?
Incidence
1
2009
682
0.040
Why?
Attitude of Health Personnel
2
1979
302
0.040
Why?
Patient Acceptance of Health Care
1
2008
123
0.040
Why?
Body Mass Index
1
2008
229
0.040
Why?
Lymphotoxin-alpha
1
2006
10
0.040
Why?
Lymphotoxin-beta
1
2006
8
0.040
Why?
Physicians, Family
1
2008
116
0.040
Why?
Interleukin-18
1
2006
11
0.040
Why?
Cancer Care Facilities
1
2006
12
0.040
Why?
Cell Proliferation
1
2010
520
0.030
Why?
Drug Evaluation, Preclinical
1
2006
79
0.030
Why?
Mice, Inbred C3H
1
2006
237
0.030
Why?
Fibrosis
1
2006
65
0.030
Why?
Radiotherapy, Adjuvant
1
2006
74
0.030
Why?
Chemotherapy, Adjuvant
1
2006
88
0.030
Why?
Adrenal Cortex Hormones
1
1986
99
0.030
Why?
Gamma Rays
1
2006
69
0.030
Why?
Nurse-Patient Relations
1
2005
9
0.030
Why?
Epidemiologic Methods
1
1985
58
0.030
Why?
Radiation Dosage
1
2005
122
0.030
Why?
Methotrexate
1
1985
73
0.030
Why?
Anoxia
1
1986
159
0.030
Why?
Tape Recording
1
1984
21
0.030
Why?
Pneumonia, Pneumocystis
1
1986
121
0.030
Why?
Practice Guidelines as Topic
1
2008
319
0.030
Why?
Respiration, Artificial
1
1986
176
0.030
Why?
Sweating
1
1984
6
0.030
Why?
Internal-External Control
1
2005
45
0.030
Why?
Alopecia
1
2004
22
0.030
Why?
Death
1
1984
23
0.030
Why?
Physician's Practice Patterns
1
2008
268
0.030
Why?
Interview, Psychological
2
1981
78
0.030
Why?
Human Experimentation
1
1984
16
0.030
Why?
Depressive Disorder
1
2008
326
0.030
Why?
Pain Measurement
1
1986
248
0.030
Why?
Combined Modality Therapy
1
2005
491
0.030
Why?
Oxygen
1
1986
495
0.030
Why?
New England
1
2002
25
0.030
Why?
Pregnancy Complications
1
2004
191
0.030
Why?
Feces
1
1982
82
0.030
Why?
Odors
1
1982
6
0.030
Why?
Random Allocation
1
1982
253
0.030
Why?
Cross-Over Studies
1
2002
119
0.030
Why?
Neurons
1
2010
1105
0.030
Why?
Fear
1
1982
50
0.030
Why?
Colonic Neoplasms
1
1982
123
0.030
Why?
Membrane Proteins
1
2006
560
0.030
Why?
Probability
1
1982
306
0.020
Why?
Reference Values
1
2002
453
0.020
Why?
Outpatient Clinics, Hospital
1
1981
44
0.020
Why?
Electromyography
1
2001
175
0.020
Why?
Infant
2
1968
2320
0.020
Why?
Electrophysiology
1
2001
249
0.020
Why?
Reading
1
1980
22
0.020
Why?
Documentation
1
1980
37
0.020
Why?
Personal Satisfaction
1
1980
35
0.020
Why?
Medicine
1
1980
31
0.020
Why?
Physical Examination
1
1980
91
0.020
Why?
Specialization
1
1980
43
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Lung
1
1986
1148
0.020
Why?
Truth Disclosure
1
1979
23
0.020
Why?
Arrhythmias, Cardiac
1
2001
237
0.020
Why?
RNA, Messenger
1
2006
1893
0.020
Why?
Vanilmandelic Acid
1
1978
6
0.020
Why?
Clinical Competence
1
1981
270
0.020
Why?
Epinephrine
1
1978
141
0.020
Why?
Norepinephrine
1
1978
252
0.020
Why?
Collagen
2
1966
301
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?
Skin Temperature
1
1995
8
0.020
Why?
Infant, Premature
2
1966
229
0.020
Why?
Monitoring, Physiologic
1
1995
110
0.020
Why?
Myocardial Infarction
1
1978
651
0.010
Why?
Appointments and Schedules
2
1981
37
0.010
Why?
Genes, Recessive
1
1968
38
0.010
Why?
Amino Acid Oxidoreductases
1
1967
39
0.010
Why?
Acidosis
1
1968
128
0.010
Why?
Fetus
1
1967
247
0.010
Why?
Adjustment Disorders
1
1985
11
0.010
Why?
Delirium, Dementia, Amnestic, Cognitive Disorders
1
1985
20
0.010
Why?
Drug Utilization
1
1985
47
0.010
Why?
Animals, Newborn
1
1967
502
0.010
Why?
Therapeutic Human Experimentation
1
1984
4
0.010
Why?
Consent Forms
1
1984
4
0.010
Why?
Trust
1
1984
30
0.010
Why?
Patient Participation
1
1984
74
0.010
Why?
Occupations
1
1983
13
0.010
Why?
Interviews as Topic
1
1984
189
0.010
Why?
Marriage
1
1983
38
0.010
Why?
Physician's Role
1
1984
142
0.010
Why?
Liver
1
1967
884
0.010
Why?
Personality Disorders
1
1983
49
0.010
Why?
Mental Health
1
1983
85
0.010
Why?
Reality Testing
1
1982
1
0.010
Why?
Psychomotor Agitation
1
1982
43
0.010
Why?
Anti-Anxiety Agents
1
1979
19
0.010
Why?
Drug Prescriptions
1
1979
43
0.010
Why?
Rats
1
1967
4389
0.010
Why?
Social Change
1
1979
23
0.010
Why?
Referral and Consultation
1
1981
207
0.010
Why?
Patient Advocacy
1
1979
50
0.010
Why?
Hypnotics and Sedatives
1
1979
86
0.010
Why?
Antipsychotic Agents
1
1979
116
0.000
Why?

Visualizations


Morrow's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department